In T2DM patients, Bote et al. were able to observe a reduction in levels of IL-8, which is the primary inducer of chemotaxis during inflammation, after patients completed 32 weeks of aquatic ET [65]. This evidence concerns the gene CXCL8 and type 2 diabetes mellitus.